Q1 2024 Holdings
Filed 2024-05-14 | 58 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $150.7M | 2,150,000 | 12.5% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $132.5M | 1,100,000 | 11.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $97.9M | 710,000 | 8.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $79.4M | 525,000 | 6.6% |
| Globus Medical Inc(GMED) | CL A | 379577208 | $53.6M | 1,000,000 | 4.4% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $53.5M | 1,250,000 | 4.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $52.3M | 350,000 | 4.3% |
| BeiGene Ltd(ONC) | SPONSORED ADR | 07725L102 | $50.8M | 325,000 | 4.2% |
| Inari Medical Inc(NARIUSD) | COM | 45332Y109 | $38.4M | 800,000 | 3.2% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $34.7M | 5,110,000 | 2.9% |
| Liquidia Corp(LQDA) | COM NEW | 53635D202 | $29.5M | 2,000,000 | 2.4% |
| ALX Oncology Holdings Inc(ALXO) | COM | 00166B105 | $29.1M | 2,610,000 | 2.4% |
| AstraZeneca PLC(AZN) | SPONSORED ADR | 046353108 | $27.1M | 400,000 | 2.2% |
| uniQure NV(QURE) | SHS | N90064101 | $24.6M | 4,725,000 | 2.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $20.3M | 750,000 | 1.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $19.7M | 50,000 | 1.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $17.2M | 400,000 | 1.4% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $16.0M | 1,050,000 | 1.3% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $15.5M | 1,100,000 | 1.3% |
| BioMarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $15.3M | 175,000 | 1.3% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $13.9M | 350,000 | 1.1% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $13.8M | 1,035,000 | 1.1% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $13.7M | 455,000 | 1.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $13.2M | 225,000 | 1.1% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $12.9M | 100,000 | 1.1% |
| Praxis Precision Medicines Inc(PRAX) | COM NEW | 74006W207 | $12.8M | 210,000 | 1.1% |
| Immatics NV(IMTX) | SHS | N44445109 | $12.6M | 1,200,000 | 1.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $11.4M | 200,000 | 0.9% |
| MacroGenics Inc(MGNX) | COM | 556099109 | $10.7M | 725,000 | 0.9% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $9.5M | 325,000 | 0.8% |
| Shockwave Medical Inc(SWAVUSD) | COM | 82489T104 | $8.1M | 25,000 | 0.7% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $8.0M | 45,000 | 0.7% |
| KalVista Pharmaceuticals Inc(KALV) | COM | 483497103 | $7.8M | 655,000 | 0.6% |
| Geron Corp(GERN) | COM | 374163103 | $7.3M | 2,200,000 | 0.6% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $7.0M | 100,000 | 0.6% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $6.9M | 100,000 | 0.6% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $6.6M | 695,000 | 0.5% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $6.2M | 75,000 | 0.5% |
| Passage Bio Inc | COM | 702712100 | $6.1M | 4,500,000 | 0.5% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $6.0M | 1,350,000 | 0.5% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $5.9M | 800,000 | 0.5% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $5.6M | 600,000 | 0.5% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $5.6M | 1,200,000 | 0.5% |
| Bio-Rad Laboratories Inc(BIO) | CL A | 090572207 | $5.2M | 15,000 | 0.4% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $5.1M | 110,000 | 0.4% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $5.0M | 800,000 | 0.4% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $4.2M | 130,000 | 0.3% |
| Alto Neuroscience Inc(ANRO) | COM SHS | 02157Q109 | $3.8M | 250,000 | 0.3% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $2.7M | 175,000 | 0.2% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $2.5M | 360,000 | 0.2% |